1. Arjanova ON, Kosheleva NG, Gromiko GL. Placentarnaya Nedostatochnost: Diagnostika i Lechenie. Uchebnoe Posobie. Saint Petersburg: Neva-Lux Press, 2001.
2. Sidorova IS and Makarov IO. Clinico-Diagnisticheskie Aspecti Fetoplacerntarnoi Nedostatochnosti. Moscow: MIA, 2005.
3. Sidelnikova VM. Privichnayay Poterya Beremennosti. Moscow: Triada-X, 2005.
4. Kauzfmann WH, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003; 69(1): 1-7.
5. Torry DS, Hinrichs M, Torry RJ. Determinants of placental vascularity. Am J Reprod Immunol 2004; 51(4): 257-268.
6. Tamura T, Johanning GL, Goldenberg RL, Johnston KE, DuBard MB. Effect of angiotensin-converting enzyme gene polymorphism on pregnancy outcome, enzyme activity, and zinc concentration. Obstet Gynecol 1996; 88(4, Pt 1): 497-502.
7. Oparil S, Haber E. The renin-angiotensin system (first of two parts). N Engl J Med 1974; 291(8): 389-401.
8. Ehlers MR, Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989; 28(13): 5311-5318.
9. Stroth U, Unger T. The renin-angiotensin system and its receptors. J Cardiovasc Pharmacol 1999; 33(Suppl 1): S21-S28.
10. Baudin B. New aspects on angiotensin-converting enzyme: from gene to disease. Clin Chem Lab Med 2002; 40(3): 256-265.
11. Buchholz T, Lohse P, Rogenhofer N, Kosian E, Pihusch R, Thaler CJ. Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages. Hum Reprod 2003; 18(11): 2473-2477.
12. Akisu M, Balim Z, Cetin H, Kosova B, Yalaz M, Topcuoglu N, Kultursay N. The role of angiotensin-converting enzyme and apolipoprotein-E polymorphisms on lipid composition in newborn infants with intrauterine growth restriction. Early Hum Dev 2004; 78(2): 95-103.
13. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86(4): 1343-1346.
14. Woods DR, Humphries SE, Montgomery HE. The ACE I/D polymorphism and human physical performance. Trends Endocrinol Metab 2000; 11(10): 416-420.
15. Hooper NM. Angiotensin-converting enzyme: implications from molecular biology for its physiological functions. Int J Biochem 1991; 23(7-8): 641-647.
16. Sambrook J, Fritsch EP, Maniatis T. Molecular Cloning: a Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory. 1989.
17. Baranov VS, Baranova EV, Ivashchenko TE, Aseev MV. Genom Cheloveka i Geni ‘Predraspolojen-nosti’ (Vvedenie v predictivnuyu meditcinu). Saint Petersburg: Intermedika, 2000.
18. Katz VL, Kuller JA. Recurrent miscarriage. Am J Perinatol 1994; 11(6): 386-397.
19. Cross JC, Baczyk D, Dobric N. Genes, development and evolution of placenta. Placenta 2003; 24(2-3): 123-130.
20. Wallenburg HCS. Placental insufficiency: pathophysiology and therapeutic approaches. Triangle 1990; 29(1): 171-180.
21. Perticone F, Ceravolo R, Maio R, Ventura R, Zingone A, Perrotti N, Mattioli PL. Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients. Hypertension 1998; 31(4): 900-905.
22. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994; 43(5): 690-695.
23. Arbustini E, Grasso M, Fasani R, Klersy C, Diegoli M, Porcu E, Banchieri N, Fortina P, Danesino C, Specchia G. Angiotensin-converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br Heart J 1995; 74(6): 584-591.
24. Mello G, Parretti E, Gensini F, Sticchi E, Mecacci F, Scarselli G, Genuardi M, Abbate R, Fatini C. Maternal-fetal flow, negative events, and preeclampsia. Role of ACE I/D polymorphism. Hypertension 2003; 41(4): 932-937.
25. Ajlamazjan EK. Akusherstvo: Uchebnik. Saint Petersburg: Specialnaya Literatura. 1997.
